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CONCLUSIONS: EQ-5D detects significant differences
in health status between patients with known mental
health problems, and is sensitive to changes in patients
with diagnosed mental illness. However, the anxiety/de-
pression dimension may have different sensitivity to its
two components.
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OBJECTIVES: The purpose of this study was to deter-
mine if order of completion of the Asthma Quality of Life
Questionnaire (AQLQ) and the Short-Form 36 (SF-36)
affected responses to domain or summary scores.
METHODS: A double-blind, randomized cost-effective-
ness trial compared triamcinolone 800 g per day versus
placebo in adult asthmatics over 12 months. Within the
clinical trial, 124 patients were randomized at the base-
line visit to one of two groups in which the order of the
self-administered health status questionnaires was alter-
nated. The first group received the AQLQ followed by
the SF-36 (N  63), and the second group was reversed
(N  61). Scores from the eight domains of the SF-36
and the four domains of the AQLQ were compared be-
tween the two groups. The groups were also compared
with regard to the overall quality of life score from the
AQLQ and the two summary scales from the SF-36.
RESULTS: The two groups did not differ significantly in
any of the domain scores, SF-36 summary scores, or the to-
tal score on the AQLQ. The overall quality of life score
from the AQLQ was 4.566 in the group that received the
AQLQ first and 4.702 in the SF-36 first group (p  0.500).
The summary estimates for the physical component sum-
mary scale (PCS) were 75.0 for the AQLQ first group and
74.1 for the SF-36 first group (p  0.589). The mental
health component summary scale (MCS) estimates were
74.3 versus 73.7 (p  0.711) for the respective groups.
CONCLUSION: The order in which questionnaires were
administered did not affect the domain or component
scores on the generic or disease specific health status
measures.
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About 270,000 surgeries for total or partial hip replace-
ment are performed annually in the United States. Pa-
tients not receiving prophylaxis agents result in an unac-
ceptably high incidence of deep vein thrombosis (DVT)
and pulmonary embolism (PE). The primary agents used
to prevent these complications are warfarin and low mo-
lecular weight heparins.
OBJECTIVES: This study examined the cost and out-
comes of hip surgery patients seen at Graduate Hospital
from October 1994 to September 1995.
METHODS: Economic and clinical outcomes data were
collected respectively for patients undergoing hip surgery
at Graduate Hospital in Philadelphia. The data were ana-
lyzed utilizing a risk adjusted outcome program devel-
oped for the Corporate Hospital Rating Project. Direct
costs were calculated using Medicare cost reporting data
by the hospital’s finance department.
RESULTS: Fifty-three patients were analyzed. Four re-
ceived both enoxaparin and warfarin, one received nei-
ther. These patients were excluded from the analysis. Re-
sults indicate the total direct cost ($6860 versus $10,320),
LOS (6.6d versus 10.5d) and complication rate (39.6%
versus 50.7%) were lower with warfarin versus enox-
aparin. Risk adjusted data also favored warfarin. There
was no evidence of DVT or PE in either group during the
6-month follow-up period after discharge.
CONCLUSIONS: The purported advantages of enox-
aparin over warfarin were not seen in our institution.
TPRD2
INCIDENCE OF SMALL-BOWEL OBSTRUCTION 
AND ADHESIOLYSIS FOLLOWING OPEN 
COLORECTAL AND GENERAL SURGERY
Beck DE1, Opelka FG1, Bailey HR2, Rauh SM3, Pashos CL4
1Ochsner Clinic, New Orleans, LA, USA; 2University of 
Texas, Houston, TX, USA; 3Rochester Colorectal Surgeons, 
Rochester, NY, USA; 4Abt Associates Clinical Trials, 
Cambridge, MA, USA
Although postsurgical adhesions following general abdomi-
nal surgery are directly responsible for negative clinical out-
comes that require additional medical management and sur-
gical re-intervention (and concomitant costs), the magnitude
of these outcomes is not readily understood. Previous stud-
ies have been primarily case series in academic centers.
OBJECTIVE: We sought to establish the incidence of small-
bowel obstruction, adhesiolysis for obstruction, and addi-
tional abdominal surgery following open colorectal and
general surgery among the elderly across all settings.
METHODS: We conducted a retrospective cohort study
using patient-specific HCFA data to evaluate a random
5% sample of all Medicare patients undergoing surgery
in 1993. Of these, 18,912 patients had an index abdomi-
nal procedure. Two-year follow-up data documented
outcomes of hospitalizations with obstruction, adhesioly-
sis for obstruction, and/or additional open colorectal or
general surgery.
